VAERS reports by lot

GSK Varicella/Shingles lot 5NY3B: VAERS reports

121 VAERS reports list lot 5NY3B as a GSK Varicella/Shingles vaccine, received between 2018-04-13 and 2018-12-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
121
Reports
6%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)11325%
Injection-site / Local reaction10423%
Dermatological (non-injection-site)5211%
Neurological5111%
Musculoskeletal5011%
Gastrointestinal358%
Allergic / Anaphylactic286%
Cardiac / Cardiovascular133%
Respiratory92%
Psychiatric / Neuropsychiatric31%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California12
New York11
Pennsylvania8
Minnesota8
North Carolina7
Missouri6
New Jersey5
Massachusetts4
Colorado4
Wisconsin4
Louisiana3
Maine3

Reports by month received

2018-047
2018-0550
2018-0627
2018-0717
2018-087
2018-099
2018-101
2018-111
2018-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.